Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
Open Access
- 21 July 2017
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (53) , 91734-91764
Abstract
The high molecular heterogeneity of bladder tumours is responsible for significant variations in disease course, as well as elevated recurrence and progression rates, thereby hampering the introduction of more effective targeted therapeutics. The implementation of precision oncology settings supported by robust molecular models for individualization of patient management is warranted. This effort requires a comprehensive integration of large sets of panomics data that is yet to be fully achieved. Contributing to this goal, over 40 years of bladder cancer glycobiology have disclosed a plethora of cancer-specific glycans and glycoconjugates (glycoproteins, glycolipids, proteoglycans) accompanying disease progressions and dissemination. This review comprehensively addresses the main structural findings in the field and consequent biological and clinical implications. Given the cell surface and secreted nature of these molecules, we further discuss their potential for non-invasive detection and therapeutic development. Moreover, we highlight novel mass-spectrometry-based high-throughput analytical and bioinformatics tools to interrogate the glycome in the postgenomic era. Ultimately, we outline a roadmap to guide future developments in glycomics envisaging clinical implementation.Keywords
This publication has 271 references indexed in Scilit:
- Molecular functions of syndecan-1 in diseaseMatrix Biology, 2012
- A glycobiology review: Carbohydrates, lectins and implications in cancer therapeuticsActa Histochemica, 2011
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosisCancer, 2010
- Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesisGlycoconjugate Journal, 2010
- Galectin-3 expression is associated with bladder cancer progression and clinical outcomeTumor Biology, 2010
- HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder CancerEuropean Urology, 2010
- Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasionCellular Signalling, 2009
- Mass Spectrometry and the Emerging Field of GlycomicsChemistry & Biology, 2008
- The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomainsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008